Department of Radiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Eur Radiol. 2018 Aug;28(8):3550-3559. doi: 10.1007/s00330-018-5325-2. Epub 2018 Feb 23.
To investigate the incidence rate, time-to-onset and recovery, MRI morphology and occurrence of insufficiency fractures in radiation-induced changes in the sacrum following pelvic radiotherapy.
410 patients with pelvic malignancies treated with radiotherapy were reviewed. Follow-up was 1-124 months (mean 22 months). Serial MRI (average four studies/patient) were analysed using a new semi-quantitative score (Radiation-Induced Sacral Changes=RISC). A size category (I/II/III), a type category for MR signal morphologies (a/b/c) and sacral insufficiency fractures (+/-) were applied.
Seventy-two patients (17.6 %) were found to have new pathological signal changes. Radiation osteitis was documented in 83.3 % (60/72, RISC stage a + b), and definite osteonecrosis (stage c) in 12 patients (16.7 %, 12/72). Thirty-one patients (43.1 %) had sacral insufficiency fractures. Initial bone marrow signal changes were found 1-35 months (median 4 months) after radiotherapy. The maximum manifestation of radiation-induced signal changes occurred after 1-35 months (mean 11 months). Fifty-six cases (77.8 %) showed a significant signal recovery within 16.5 months.
Radiation-induced bone marrow changes appear with a high incidence at the sacrum with an early onset and frequent recovery. The majority presented a pattern of radiation osteitis, whereas osteoradionecrosis was proportionately rare.
• Radiation-induced sacral bone marrow changes appear frequently (17.6 %) following pelvic radiotherapy. • Insufficiency fractures are common late effects (43 %). • Radiation osteitis develops early (4 mo), with recovery between 16.5 and 39.5 months. • Definite radiological osteoradionecrosis is proportionately rare (3 %). • A 3-stage classification system simplifies and standardizes the morphological disease staging.
研究盆腔放疗后骶骨放射性改变的发生率、发病时间、恢复情况、MRI 形态和骨不连的发生。
回顾性分析 410 例接受盆腔放疗的恶性肿瘤患者。随访时间为 1-124 个月(平均 22 个月)。采用新的半定量评分(放射性骶骨改变评分=RISC)对连续 MRI(平均每个患者 4 次研究)进行分析。应用大小分类(I/II/III)、MR 信号形态分类(a/b/c)和骶骨骨不连(+/-)。
72 例(17.6%)患者出现新的病理性信号改变。放射性骨炎 83.3%(60/72,RISC 阶段 a+b),明确的骨坏死(阶段 c)12 例(16.7%,12/72)。31 例(43.1%)患者发生骶骨骨不连。放射后 1-35 个月(中位数 4 个月)首次发现骨髓信号改变。放射性信号改变的最大表现发生在放射后 1-35 个月(平均 11 个月)。56 例(77.8%)在 16.5 个月内显示明显信号恢复。
骨盆放疗后骶骨骨髓放射性改变发生率高,发病早,恢复频繁。多数表现为放射性骨炎,而放射性骨坏死相对少见。
•盆腔放疗后骶骨骨髓放射性改变发生率高(17.6%)。•骨不连是常见的晚期并发症(43%)。•放射性骨炎早期发生(4 个月),16.5-39.5 个月恢复。•明确的放射性骨坏死相对少见(3%)。•3 期分类系统简化和规范了形态学疾病分期。